Myriad (MYGN) Issues Response to Supreme Court Decision on Gene Patent
Go back to Myriad (MYGN) Issues Response to Supreme Court Decision on Gene Patent| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 2.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.87 | 52 Week High | $45.34 | |||
| Open | $2.87 | 52 Week Low | $15.92 | |||
| Day High | $2.87 | P/E | 1.23 | |||
| Day Low | $2.87 | EPS | $2.33 | |||
| Volume | 471 | |||||
